abnormal range, (sodium greater than 60 mmol/l, chloride greater than 70 mmol/l).
Results of sweat tests performed while subjects were taking oral flucloxacillin also showed a clear demarcation between the two groups (figure). There was no significant difference between the two sets of results-that is, on and off flucloxacillin (Wilcoxon signed rank test:p>0-5) in either group.
Discussion
It has been suggested that substitution of the chloride ion by cloxacillin may occur and artefactually produce unusually low sweat chloride results' causing difficulty in confirming the diagnosis of cystic fibrosis. Our study disproves this hypothesis and confirms that there is no contraindication to sweat testing while a subject is taking oral flucloxacillin.
The possibility that the artefactually low chloride results were due to analytical interference exists as our method differs from that (modified Schales and Schales) used by Griffiths death in days (corrected for prematurity), sex, crown to heel length, and weight. They were divided into three groups according to type of diagnosis; unexplained death (n=62), death after a sudden acute illness in a previously well child (n=18), and death after a chronic illness (n=12).
In all cases specimens of the right fifth rib including the costochondral junction were taken and stored and transported in a buffered calcium forma-lin solution to prevent deterioration of the mineral content. Single photon absorptiometry was carried out as previously described.3 Each rib was scanned 1-5 cm from the costochondral junction unless it was shorter than that, when it was scanned at its midpoint. As width of rib in the two groups. The results indicate that disturbances in the formation of cartilage seen by others are not longstanding enough or severe enough to cause a measurable reduction in the mineral content of ribs in a study of this size. Reduced mineral content in ribs of infants dying of chronic illnesses was expected as studies in the neonates have shown that undernutrition (relative to the nutrition provided by the placenta when it is functioning correctly) may result in pronounced reductions in the mineral content of bone.4
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Functional residual capacity related to hepatic disease A GREENOUGH, J POOL, C BALL, G MIELI-VERGANI, AND A MOWAT Department of Child Health, King's College Hospital, London SUMMARY Functional residual capacity was measured in 20 children (aged 3-1-11-2 years) with liver disease. Children with severe liver disease, regardless of diagnosis, had reduced functional residual capacities (<80% of expected). Children with a-I antitrypsin deficiency had higher functional residual capacities than those with other hepatic diagnoses. Three children had a functional residual capacity >120% of expected, all had a-I antitrypsin deficiency.
In childhood a-I antitrypsin deficiency is usually associated with liver disease, but it has been suggested that asthma and bronchitis may be commoner in children over 8 years of age with a-I antitrypsin deficiency.' No respiratory measurements, however, were performed and the authors were unable to comment whether the symptoms were early manifestations of emphysema.'
Recently it has become possible to measure functional residual capacity by helium gas dilution reproducibly and accurately even in children as young as 2 years of age.2 3 The aim of the present study, using this technique,2 3 was to determine if abnormalities of functional residual capacity were present in young children with a-1 antitrypsin deficiency. Secondly, by comparing their results with those of children with other hepatic diagnosis, we aimed to determine whether the abnormalities specifically related to a-1 antitrypsin deficiency rather than a non-specific effect of hepatic disease.
Patients and methods
Twenty children attending the paediatric liver service at King's College Hospital were studied. Only one child, who had previously been diagnosed as suffering from asthma, had respiratory symptoms. Twelve children suffered from a-I antitrypsin deficiency (five boys and seven girls, median age 5 years (range 3-1-11-5 years)). Eight other children were also studied: five with biliary atresia, two who had had neonatal hepatitis, and one with congenital hepatic fibrosis. This latter group, who were designated controls, consisted of three boys and five girls with a median age 4-5 years (range 3*5-8 6 years). The children in both groups were classified into four subgroups according to disease severity (figure).
Ethical permission for the study was granted by King's College Hospital ethical committee ano parental consent was obtained.
All children had their functional residual capacity measured by helium gas dilution using a water sealed spirometer (Gould Pulmonet 3) in the paediatric respiratory laboratory.2 3 All recordings were coded and then analysed blind of the child's clinical details. Each child's results were compared with published normal data2 or data collected from 60 healthy children of similar ages to the study population. Functional residual capacity was ex-infant deaths. 
Mineral content of rib bone in

